Tectonic Therapeutic Inc

In a Stage 2 advance with higher highs and higher lows intact, medium- and long-term biases remain bullish, supported by rising EMAs and constructive volume. Short-term price is churning around flat-to-rising 9/21 and 50 EMAs without a clear directional edge, so we defer execution. We will look to buy on a decisive pullback into the EMA cluster or on a breakout above recent consolidation.

• ↑TECX up 26.2% in past two weeks, driven by heavy buying
• ↑10-day MA crossed above 50-day MA, signaling sustained uptrend
• ↓Negative earnings yield points to unprofitable core operations